For the past seven years, the Geoffrey Beene Cancer Research Center (GBCRC) at Memorial Sloan Kettering has been giving investigators direct support to explore new and revolutionary ideas through a progressive model of funding. To date, the Geoffrey Beene Foundation and Geoffrey Beene, LLC, have awarded a total of $132 million to this collaborative research center, which brings together investigators from the Sloan Kettering Institute’s Cancer Biology and Genetics Program and the Human Oncology and Pathogenesis Program.
“The Geoffrey Beene Center takes a new approach to modern cancer research with the ultimate goal of translating basic discoveries into new ways to think about treating cancer,” says GBCRC Chair Scott W. Lowe, who is Chair of the Cancer Biology and Genetics Program and a Howard Hughes Medical Institute investigator.
